Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 公司成立于2004年12月22日,经北京市工商行政管理局海淀分局批准注册登记,统一社会信用代码为91110108769900489W。截至2020年12月31日,本公司注册资本100,000,000.00元,实收资本100,000,000.00元,注册地址:北京市海淀区开拓路5号3层A305,办公地址:北京市大兴区永旺西路26号院2号楼1-4楼。法定代表人:胡刚。本公司主要经营活动:医学研究与试验发展;提供技术转让、技术咨询、技术服务;研究开发医疗器械、医用新药;销售自产产品;佣金代理(拍卖除外);货物进出口、代理进出口、技术进出口;销售医疗器械Ⅲ类(以《医疗器械经营企业许可证》核定的范围为准);生产医疗器械Ⅲ类(以《医疗器械生产企业许可证》核定的范围为准)。(依法须经批准的项目,经相关部门批准后依批准的内容开展经营活动。)本公司的实际控制人为崔福斋、黄晚兰、胡刚。 公司成立于2004年,是一家专注于高端生物医用材料及相关医疗器械产品的研发、生产及销售的国家级高新技术企业。自成立以来,发行人始终以通过产品和技术的持续创新满足临床需求为导向,主要围绕矿化胶原人工骨修复材料领域进行研究与开发,于2011年推出了矿化胶原人工骨修复材料医疗器械产品,完成了矿化胶原人工骨修复材料的临床转化和产业化,并建立了具有完整知识产权的体外仿生矿化技术平台。依托上述技术平台,发行人针对不同科室的临床需求进行产品研发,陆续推出了一系列矿化胶原人工骨修复产品。截至目前,发行人的“骼金”、“齿贝”、“颅瑞”产品均已取得中国第III类医疗器械产品注册证,分别用于骨科、口腔或整形外科、神经外科的骨缺损修复,已应用于包括国内多家知名三甲医院在内的四百多家医院,临床使用超过百万例;“BonGold”产品已取得美国FDA510(k)市场准入许可,用于骨科的骨缺损修复,成为我国首个也是目前唯一获得美国FDA510(k)市场准入许可的国产人工骨修复产品。 | ||||||||||||||||||||||||
Main Business | 专注于高端生物医用材料及相关医疗器械产品的研发、生产及销售。 | ||||||||||||||||||||||||
Legal Representative | Eric Gang Hu(胡刚) | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 仇志烨 | ||||||||||||||||||||||||
Solicitors | 北京观韬中茂律师事务所 | ||||||||||||||||||||||||
Auditors | 立信会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 010-56330938 | ||||||||||||||||||||||||
Fax No | 010-56330939;010-56330938 | ||||||||||||||||||||||||
Website | www.allgensmed.cn | ||||||||||||||||||||||||
information@allgensmed.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 21/05/2021 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.410 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.060 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 10.366 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 2.597B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |